BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20564001)

  • 21. An Arthritis-Suppressive and Treg Cell-Inducing CD4+ T Cell Epitope Is Functional in the Context of HLA-Restricted T Cell Responses.
    de Wolf C; van der Zee R; den Braber I; Glant T; Maillère B; Favry E; van Lummel M; Koning F; Hoek A; Ludwig I; van Eden W; Broere F
    Arthritis Rheumatol; 2016 Mar; 68(3):639-47. PubMed ID: 26414917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis.
    Doodes PD; Cao Y; Hamel KM; Wang Y; Rodeghero RL; Mikecz K; Glant TT; Iwakura Y; Finnegan A
    J Immunol; 2010 Feb; 184(3):1552-9. PubMed ID: 20028652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis.
    Kaplan C; Valdez JC; Chandrasekaran R; Eibel H; Mikecz K; Glant TT; Finnegan A
    Arthritis Res; 2002; 4(1):54-8. PubMed ID: 11879537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.
    Glant TT; Radacs M; Nagyeri G; Olasz K; Laszlo A; Boldizsar F; Hegyi A; Finnegan A; Mikecz K
    Arthritis Rheum; 2011 May; 63(5):1312-21. PubMed ID: 21305522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB/c mice.
    Buzás EI; Brennan FR; Mikecz K; Garzó M; Negroiu G; Holló K; Cs-Szabó G; Pintye E; Glant TT
    J Immunol; 1995 Sep; 155(5):2679-87. PubMed ID: 7544381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of proteoglycan-reactive T cell lines and hybridomas from mice with proteoglycan-induced arthritis.
    Leroux JY; Poole AR; Webber C; Vipparti V; Choi HU; Rosenberg LC; Banerjee S
    J Immunol; 1992 Apr; 148(7):2090-6. PubMed ID: 1372024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Class II major histocompatibility complex-peptide tetramer staining in relation to functional avidity and T cell receptor diversity in the mouse CD4(+) T cell response to a rheumatoid arthritis-associated antigen.
    Falta MT; Fontenot AP; Rosloniec EF; Crawford F; Roark CL; Bill J; Marrack P; Kappler J; Kotzin BL
    Arthritis Rheum; 2005 Jun; 52(6):1885-96. PubMed ID: 15934080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen-specific T cells transduced with IL-10 ameliorate experimentally induced arthritis without impairing the systemic immune response to the antigen.
    Setoguchi K; Misaki Y; Araki Y; Fujio K; Kawahata K; Kitamura T; Yamamoto K
    J Immunol; 2000 Nov; 165(10):5980-6. PubMed ID: 11067961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.
    Tang B; Kim S; Hammond S; Cullins DL; Brand DD; Rosloniec EF; Stuart JM; Postlethwaite AE; Kang AH; Myers LK
    Arthritis Res Ther; 2014 Jan; 16(1):R7. PubMed ID: 24405551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system.
    Bárdos T; Mikecz K; Finnegan A; Zhang J; Glant TT
    J Immunol; 2002 Jun; 168(12):6013-21. PubMed ID: 12055209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-6 plays a unique role in initiating c-Maf expression during early stage of CD4 T cell activation.
    Yang Y; Ochando J; Yopp A; Bromberg JS; Ding Y
    J Immunol; 2005 Mar; 174(5):2720-9. PubMed ID: 15728480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4(+) T cells from glutamic acid decarboxylase (GAD)65-specific T cell receptor transgenic mice are not diabetogenic and can delay diabetes transfer.
    Tarbell KV; Lee M; Ranheim E; Chao CC; Sanna M; Kim SK; Dickie P; Teyton L; Davis M; McDevitt H
    J Exp Med; 2002 Aug; 196(4):481-92. PubMed ID: 12186840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
    Glant TT; Mikecz K
    Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous nasal administration of antigen is critical to maintain tolerance in adoptively transferred autoimmune arthritis in SCID mice.
    Bárdos T; Czipri M; Vermes C; Zhang J; Mikecz K; Glant TT
    Clin Exp Immunol; 2002 Aug; 129(2):224-31. PubMed ID: 12165077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice.
    Gebe JA; Unrath KA; Yue BB; Miyake T; Falk BA; Nepom GT
    J Autoimmun; 2008 Jun; 30(4):197-206. PubMed ID: 17949947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific B cells present cartilage proteoglycan (aggrecan) to an autoreactive T cell hybridoma derived from a mouse with proteoglycan-induced arthritis.
    Brennan FR; Mikecz K; Buzás EI; Ragasa D; Cs-Szabó G; Negroiu G; Glant TT
    Clin Exp Immunol; 1995 Sep; 101(3):414-21. PubMed ID: 7664487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B cell-specific expression of inducible costimulator ligand is necessary for the induction of arthritis in mice.
    Hamel KM; Cao Y; Olalekan SA; Finnegan A
    Arthritis Rheumatol; 2014 Jan; 66(1):60-7. PubMed ID: 24449576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different development of myelin basic protein agonist- and antagonist-specific human TCR transgenic T cells in the thymus and periphery.
    Kawamura K; Yao K; Shukaliak-Quandt JA; Huh J; Baig M; Quigley L; Ito N; Necker A; McFarland HF; Muraro PA; Martin R; Ito K
    J Immunol; 2008 Oct; 181(8):5462-72. PubMed ID: 18832703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differentiated state of intestinal lamina propria CD4+ T cells results in altered cytokine production, activation threshold, and costimulatory requirements.
    Hurst SD; Cooper CJ; Sitterding SM; Choi Jh; Jump RL; Levine AD; Barrett TA
    J Immunol; 1999 Dec; 163(11):5937-45. PubMed ID: 10570280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient inhibition of interleukin 4 signaling by T cell receptor ligation.
    Zhu J; Huang H; Guo L; Stonehouse T; Watson CJ; Hu-Li J; Paul WE
    J Exp Med; 2000 Oct; 192(8):1125-34. PubMed ID: 11034602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.